Sangamo BioSciences Announces Presentation At The Cowen And Company 36th Annual Health Care Conference

March 1, 2016 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced today that Edward Lanphier, Sangamo's president and chief executive officer, will provide an update on the progress of Sangamo's ZFP Therapeutic^® development programs and an overview of the company's business strategy at 10:40 am ET on Wednesday, March 9, 2016, at the Cowen and Company 36^th Annual Health Care Conference. The conference is being held in Boston from March 7-9, 2016.